(Washington, D.C.) — The Personal Care Products Council (PCPC) and Consumer Healthcare Products Association (CHPA) submitted comments to the U.S. Food & Drug Administration (FDA) in response to the Sunscreen Tentative Final Monograph (TFM).
The industry organizations note sunscreens are important products that protect consumers from the harmful effects of ultra-violet (UV) radiation and, most importantly, play a critical role in the fight against skin cancer — the most common form of cancer in the United States. FDA recently said, “given the recognized public health benefits of sunscreen use, Americans should continue to use sunscreen with other sun protective measures as this important rulemaking effort moves forward.”
The comments submitted by PCPC and CHPA, together with their member companies, outlined suggestions to the TFM that will help the industry continue to formulate a broad range of innovative sunscreen products that help protect consumers from the harmful effects of the sun’s UV rays while accommodating their product preferences. The Executive Summary can be found here.
Industry is committed to continue working in partnership with FDA to develop a work-plan for identifying existing data and generating additional data to support the safety of sunscreen active ingredients. Ultimately, having a greater number of sunscreen filters allows manufacturers to formulate safe and effective products to meet the diverse needs of individuals and their families, while providing necessary protection against the damaging effects of the sun.
Contacts:
Lisa Powers, 202.466.0489, powersl@personalcarecouncil.org
